A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors
2017 ◽
Vol 36
(1)
◽
pp. 36-44
◽
Keyword(s):
Phase I
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3034-3034
◽
2014 ◽
Vol 73
(3)
◽
pp. 539-549
◽
2014 ◽
Vol 20
(24)
◽
pp. 6284-6294
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 2531-2531
◽